156 related articles for article (PubMed ID: 38775151)
1. Double-faced CX3CL1 enhances lymphangiogenesis-dependent metastasis in an aggressive subclone of oral squamous cell carcinoma.
Eain HS; Kawai H; Nakayama M; Oo MW; Ohara T; Fukuhara Y; Takabatake K; Shan Q; Soe Y; Ono K; Nakano K; Mizukawa N; Iida S; Nagatsuka H
JCI Insight; 2024 May; 9(10):. PubMed ID: 38775151
[TBL] [Abstract][Full Text] [Related]
2. Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma.
Lien MY; Tsai HC; Chang AC; Tsai MH; Hua CH; Wang SW; Tang CH
Front Immunol; 2018; 9():412. PubMed ID: 29599774
[TBL] [Abstract][Full Text] [Related]
3. CX3CL1 induces cell migration and invasion through ICAM-1 expression in oral squamous cell carcinoma cells.
Wu CY; Peng PW; Renn TY; Lee CJ; Chang TM; Wei AI; Liu JF
J Cell Mol Med; 2023 Jun; 27(11):1509-1522. PubMed ID: 37082943
[TBL] [Abstract][Full Text] [Related]
4. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-29b regulates migration in oral squamous cell carcinoma and its clinical significance.
Yang CN; Deng YT; Tang JY; Cheng SJ; Chen ST; Li YJ; Wu TS; Yang MH; Lin BR; Kuo MY; Ko JY; Chang CC
Oral Oncol; 2015 Feb; 51(2):170-7. PubMed ID: 25435433
[TBL] [Abstract][Full Text] [Related]
6. Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.
Wang SH; Chang JS; Hsiao JR; Yen YC; Jiang SS; Liu SH; Chen YL; Shen YY; Chang JY; Chen YW
Oncogene; 2017 Mar; 36(11):1503-1515. PubMed ID: 27593938
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
[TBL] [Abstract][Full Text] [Related]
8. Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma.
Sasabe E; Tomomura A; Tomita R; Sento S; Kitamura N; Yamamoto T
PLoS One; 2017; 12(11):e0188965. PubMed ID: 29190834
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
[TBL] [Abstract][Full Text] [Related]
10. HPV-positive murine oral squamous cell carcinoma: development and characterization of a new mouse tumor model for immunological studies.
Modic Z; Cemazar M; Markelc B; Cör A; Sersa G; Kranjc Brezar S; Jesenko T
J Transl Med; 2023 Jun; 21(1):376. PubMed ID: 37296466
[TBL] [Abstract][Full Text] [Related]
11. Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma.
Morita Y; Hata K; Nakanishi M; Omata T; Morita N; Yura Y; Nishimura R; Yoneda T
Clin Exp Metastasis; 2015 Oct; 32(7):739-53. PubMed ID: 26319373
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
[TBL] [Abstract][Full Text] [Related]
13. Laminin γ2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via integrin α3-dependent uptake by lymphatic endothelial cells.
Wang SH; Liou GG; Liu SH; Chang JS; Hsiao JR; Yen YC; Chen YL; Wu WL; Chang JY; Chen YW
Int J Cancer; 2019 Jun; 144(11):2795-2810. PubMed ID: 30485433
[TBL] [Abstract][Full Text] [Related]
14. Silencing Id-1 inhibits lymphangiogenesis through down-regulation of VEGF-C in oral squamous cell carcinoma.
Dong Z; Wei F; Zhou C; Sumida T; Hamakawa H; Hu Y; Liu S
Oral Oncol; 2011 Jan; 47(1):27-32. PubMed ID: 21111670
[TBL] [Abstract][Full Text] [Related]
15. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
Miyahara M; Tanuma J; Sugihara K; Semba I
Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
[TBL] [Abstract][Full Text] [Related]
18. Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment.
Routray S; Kheur S; Chougule HM; Mohanty N; Dash R
Ann Diagn Pathol; 2017 Oct; 30():36-41. PubMed ID: 28965626
[TBL] [Abstract][Full Text] [Related]
19. The miR-561-5p/CX
Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z
Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of homeodomain-interacting protein kinase 2 promotes oral squamous cell carcinoma metastasis through inhibition of P53-dependent E-cadherin expression.
Zheng X; Pan Y; Chen X; Xia S; Hu Y; Zhou Y; Zhang J
Cancer Sci; 2021 Jan; 112(1):117-132. PubMed ID: 33063904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
